Results 121 to 130 of about 4,490 (182)

Glioblastoma, <i>IDH-</i>wildtype, with a novel <i>MEF2D-NTRK1</i> gene fusion: a case report. [PDF]

Front Oncol
Dewey A, Baranda JC, Zhang W, Haeri M, Milligan B, Tuncer T.   +5 more
europepmc   +1 more source

Discovery of novel repurposed anthelminthics against <i>Trichinella spiralis</i> and albendazole-resistant nematodes through metabolomics-guided virtual screening. [PDF]

Curr Res Parasitol Vector Borne Dis
Chienwichai P, Tipthara P, Tarning J, Thiangtrongjit T, Supasawat P, Adisakwattana P, Reamtong O.   +6 more
europepmc   +1 more source

Entrectinib binds to HMGB1 and activates cardiomyocyte autophagy by inhibiting OTUD5-MTORC1 signaling to induce cardiotoxicity. [PDF]

Autophagy
Gao Z, Zhang J, Fu H, Zhang S, Chen J, Zhou H, Chen X, Zhang X, Yan H, Yang B, He Q, Xu Z, Luo P.   +12 more
europepmc   +1 more source

<i>ROS1</i>-positive non-small cell lung cancer: from genomics to treatment decisions. [PDF]

Front Oncol
Wespiser M, Gille R, Pérol M.
europepmc   +1 more source

Dramatic response to entrectinib in a rare glioneuronal tumor harboring an NTRK2 fusion. [PDF]

Oncologist
Akrout F, Bogumil H, Yedeas MD, Sievers P, Touat M, Achoura S.   +5 more
europepmc   +1 more source

An evaluation of taletrectinib for the treatment of ROS1+ non-small cell lung cancer. [PDF]

Expert Rev Anticancer Ther
Samaeekia R, Arter Z, Nagasaka M.
europepmc   +1 more source

First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring <i>ROS1</i> Rearrangement: Exploring the Role of Next-Generation Sequencing in Targeted Therapy. [PDF]

Int J Mol Sci
Tang YJ, Chen RH, Lu YS, Wu CE.
europepmc   +1 more source

High-throughput transcriptomic screening reveals entrectinib as a repositioning opportunity in 19q12 autism spectrum disorder. [PDF]

Sci Rep
Guin D, Haditsch U, Bellucci JJ, Topka S, Dyer KE, Del Toro GAR, Blanco MR, Downs NF, Perfito N, Mahadevan A, Moxham CM.   +10 more
europepmc   +1 more source

Regulatory Perspectives in Precision Oncology: Challenges and Opportunities for Tyrosine Receptor Kinase (NTRK) Inhibitors in Non-small Cell Lung Cancer (NSCLC). [PDF]

Cureus
Gainor J, Popat S, Bundy L.
europepmc   +1 more source

Corticosteroids for Managing TRK Inhibitor Withdrawal Pain: A Report on Two Cases. [PDF]

Curr Oncol
Marcoux N, Grenier LP.
europepmc   +1 more source